Translational Andrology and Urology received its first Impact Factor: 2.113

Published: 2019-06-21

We are pleased to announce that Translational Andrology and Urology(TAU) has received its first impact factor of 2.113 for the year 2018. 

The impact factor, as published in the annual Journal Citation Reports (JCR), is a calculation determined based on the number of citations accumulated in 2018 for manuscripts published in 2016 and 2017. 

Translational Andrology and Urology is an open access, peer-reviewed, bi-monthly journal indexed by PubMed/PubMed Central and Science Citation Indexed Expanded (SCIE). It covers various aspects in diseases of male and female urinary tract including kidneys, ureters, bladder and urethra and the male reproductive organs like penis, testes, scrotum, prostate etc.

The announcement of the journal’s first impact factor is not only a significant achievement for the journal, but it is also the beginning of developing a more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our editorial board members, guest editors, authors, and reviewers for their significant contributions. We look forward to the continuous cooperation with all the above mentioned and those who are interested in translational andrology and urology research to bring more exciting content to readers in the coming future.

Editorial Office
Translational Andrology and Urology
June 21, 2019